Showing results (301-310 of 352) with videos related to

Sort By:
Pageof 36
Journal of the American Society of Nephrology : JASN|January 10, 2015
Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical TrialJeffrey B Kopp, Cheryl A Winkler, Xiongce Zhao, et al.
Ebiomedicine|December 19, 2020
Discoidin domain receptor 1 activation links extracellular matrix to podocyte lipotoxicity in Alport syndromeJin-Ju Kim, Judith M David, Sydney S Wilbon, et al.
The Journal of Clinical Investigation|August 3, 2016
Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injuryChristopher E Pedigo, Gloria Michelle Ducasa, Farah Leclercq, et al.
The Journal of Clinical Investigation|July 23, 2019
ATP-binding cassette A1 deficiency causes cardiolipin-driven mitochondrial dysfunction in podocytesG Michelle Ducasa, Alla Mitrofanova, Shamroop K Mallela, et al.
Atherosclerosis|July 22, 2017
Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomesAyman Samman Tahhan, Salim S Hayek, Pratik Sandesara, et al.
Journal of the American Society of Nephrology : JASN|November 10, 2012
Circulating suPAR in two cohorts of primary FSGSChangli Wei, Howard Trachtman, Jing Li, et al.
Journal of the American Society of Nephrology : JASN|March 9, 2017
Targeting mTOR Signaling Can Prevent the Progression of FSGSStefan Zschiedrich, Tillmann Bork, Wei Liang, et al.
The Journal of Biological Chemistry|December 4, 2016
Absence of miR-146a in Podocytes Increases Risk of Diabetic Glomerulopathy via Up-regulation of ErbB4 and Notch-1Ha Won Lee, Samia Q Khan, Shehryar Khaliqdina, et al.
Pageof 36